How to Recognize and Treat Hidden Inflammation How to Recognize and Treat Hidden Inflammation
IgG4-associated diseases have likely been around for some time, but only in the past 10 years has awareness grown that they are all the same disease.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - February 17, 2023 Category: Rheumatology Tags: Rheumatology News Source Type: news
New Tool Better Estimates CV Risk in People With Lupus New Tool Better Estimates CV Risk in People With Lupus
A tool to estimate cardiovascular risk in systemic lupus erythematosus incorporates disease-specific variables.MDedge News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - February 16, 2023 Category: Rheumatology Tags: Rheumatology News Source Type: news
Pay An Annual Visit to Your Office Pay An Annual Visit to Your Office
In this month ' s column, Dr Eastern asks, ' When was the last time you did a comprehensive inspection, looking for problems that your patients might see? 'MDedge (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - January 23, 2023 Category: Rheumatology Tags: Dermatology Commentary Source Type: news
Phil Robinson: Rheumatologist, Colleague, Huntsman Spider Rescuer Phil Robinson: Rheumatologist, Colleague, Huntsman Spider Rescuer
Philip ("Phil") Robinson, rheumatologist and associate professor at the University of Queensland and leader of global effort to understand COVID-19 among patients with rheumatic conditions, died on January 3 after a brief illness.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - January 19, 2023 Category: Rheumatology Tags: Rheumatology News Source Type: news
DMARDs for RA Improve Vascular Inflammation and CV Risk DMARDs for RA Improve Vascular Inflammation and CV Risk
Receipt of a tumor necrosis factor inhibitor or triple therapy for rheumatoid arthritis yielded an equally beneficial effect for reducing vascular inflammation and cardiovascular risk.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - December 8, 2022 Category: Rheumatology Tags: Rheumatology News Source Type: news
Wide Variance Described in Monitoring of Conventional DMARDs Wide Variance Described in Monitoring of Conventional DMARDs
"Everyone is doing something different, which means that the system likely has a lot of low-value activity and that money is being wasted," said senior author Philip C. Robinson, MBChB, PhD.MDedge News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - November 28, 2022 Category: Rheumatology Tags: Rheumatology News Source Type: news
First Classification Criteria Proposed for Chronic Osteomyelitis First Classification Criteria Proposed for Chronic Osteomyelitis
The disease and its more severe form, chronic recurrent multifocal osteomyelitis, have been diagnosed by exclusion, which can delay treatment and referral.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - November 18, 2022 Category: Rheumatology Tags: Rheumatology News Source Type: news
Celiac Disease Linked to Higher Risk for RA, JIA Celiac Disease Linked to Higher Risk for RA, JIA
Clinicians caring for patients with celiac disease should have a low threshold to evaluate arthritic conditions.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - November 17, 2022 Category: Rheumatology Tags: Gastroenterology News Source Type: news
Vitamin D Deficiency Causes Death, New Study Finds Vitamin D Deficiency Causes Death, New Study Finds
A genetic approach provides support for the effects of vitamin D on mortality. The benefits of Vitamin D supplementation are largely found in those with deficiency, researchers find.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - October 24, 2022 Category: Rheumatology Tags: Diabetes & Endocrinology News Source Type: news
Two Biologics Equally Effective for EIM of IBD Two Biologics Equally Effective for EIM of IBD
Ustekinumab and vedolizumab have similar effects on extraintestinal manifestations of inflammatory bowel disease, a real-world, retrospective analysis finds.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - October 22, 2022 Category: Rheumatology Tags: Gastroenterology News Source Type: news
Body Temperature Triggers Flares in Autoinflammatory Disorder Body Temperature Triggers Flares in Autoinflammatory Disorder
New mouse models demonstrating how higher body temperature reduces levels of mevalonate kinase can serve as ' preclinical platforms ' to test the efficacy and safety of possible treatments.MDedge News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - October 10, 2022 Category: Rheumatology Tags: Rheumatology News Source Type: news
Antifibrotic Shows Mixed Results in RA-ILD Antifibrotic Shows Mixed Results in RA-ILD
Adding pirfenidone did not change decline in forced vital capacity or mortality risk, but may slow rate of lung function decline.MDedge News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - October 10, 2022 Category: Rheumatology Tags: Pulmonary Medicine News Source Type: news
Could Vitamin C Help Reduce Gout? Could Vitamin C Help Reduce Gout?
Lifestyle interventions are seen as particularly relevant to a disease like gout.WebMD Health News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - October 6, 2022 Category: Rheumatology Tags: Rheumatology News Source Type: news
Could Exercise Improve Bone Health in Youth With Type 1 Diabetes? Could Exercise Improve Bone Health in Youth With Type 1 Diabetes?
Weight-bearing activities may strengthen bone and reduce fractures in youth with type 1 diabetes, a small cross-sectional study of girls with or without type 1 diabetes suggests, but more research is needed.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - September 20, 2022 Category: Rheumatology Tags: Diabetes & Endocrinology News Source Type: news
Sustained Response at 2 Years Reported for Deucravacitinib Sustained Response at 2 Years Reported for Deucravacitinib
Deucravacitinib, an oral, selective tyrosine kinase 2 (TYK2) inhibitor, was approved September 9 by the FDA for treating adults with moderate to severe plaque psoriasis.MDedge News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - September 15, 2022 Category: Rheumatology Tags: Dermatology News Source Type: news
